Straumann Holding Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Straumann Holding Ltd Comments on FY 2013 Guidance
Straumann Holding Ltd announced that its fiscal year 2013 revenue is expected to be at least in-line with the prior fiscal year 2012 in organic terms.
Latest Key Developments in Medical
- Antares Pharma Inc announces publication of a head-to-head, randomized, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis
- Baxter International Inc gives Q2 2014 revenue outlook above analysts' estimates, Q2 2014 EPS outlook below analysts' estimates; reaffirms FY 2014 outlook
- Baxter International invests to construct facility of $1 billion
- Amplifon SpA increases stake to 63 pct in Amplifon Poland
- Share this
- Digg this